Aiming to address this demand for increased training, the course provides the information needed to understand the most important health practice and product regulation issues in the US and abroad from the perspective of current regulatory standards, their standards for evidence, and the role of innovation in regulatory science. Building regulatory capacity is important for the US as well as for the rest of the world. This new exciting area of science requires a new generation of trained regulatory experts and professionals in academic, government, industry, and public health sectors. Innovation is needed to address the 21st century’s evolving regulatory landscape, in the context of new technologies, new understanding of diseases, and a sharpened lens on safety. This interdisciplinary regulatory science course brings together participants working in regulatory agencies, public health, law, medicine, business, and policy to gain an understanding of the most prominent product regulation issues in the US and abroad. To register, please visit the course catalog here. Regulatory Science, Drug Development, and Public Health (PHW236A) will be offered online by the UC Berkeley School of Public Health in the Fall of 2022 PH 290: Diagnostics in Infectious Diseases: Development and Regulatory Challenges.Food and Drug Administration, Drug Development, Public Health And Health Policy PHW 236A Regulatory Science, Drug Development and Public Health Online Course.Translating Real-World Data into Real-World Evidence Project Overview.Bartlett Award for Catalyzing Clinical Research to Improve Global Health Everett Koop Public Health Leadership Award 2012 National Summit on HIV and Viral Hepatitis.2015 National Summit on HCV and HIV Diagnosis, Prevention and Access to Care.
0 kommentar(er)
